CV Sciences, Inc. Announces Launch of CV Defense Daily Immune Support - Seite 2

“We evaluated hundreds of ingredients that would bring the strongest reinforcements to immune defense and make the most meaningful impact on health and wellness,” said Joseph Dowling, Chief Executive Officer of CV Sciences. “CV Defense is a unique formulation that is proven to provide daily immune support, which is critically important as we head into 2020/2021 flu season.”

Dowling continued, “Our launch of CV Defense represents another key milestone in our strategic category expansion and continued evolution of CV Sciences’ positioning as a leading health and wellness company. We are pleased to make CV Defense broadly available and accessible to consumers through our website and Amazon.com, further supporting our ability to bring immunity health products to market. In addition, we believe that our CBD product line will be ideal companion products to our Immunity line since CBD supports the endocannabinoid system (ECS), and a healthy ECS supports immune health.”

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based dietary supplements and CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics. The Company’s PlusCBD products are sold at more than 6,300 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry.  CV Sciences follows all guidelines for Good Manufacturing Practices (GMP) and the Company’s products are processed, produced, and tested throughout the manufacturing process to confirm strict compliance with company standards and specifications.  With a commitment to science, PlusCBD product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov.  PlusCBD was the first hemp CBD supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. CV Sciences, Inc. has primary offices and facilities in San Diego, California.  Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.